Medtronic has suspended US shipment of products, including external defibrillators, from the Redmond, Washington facility of its emergency response systems business, Physio-Control. It said the suspension was intended "to address quality system issues in [the] facility that were identified by Physio-Control, Medtronic and the US FDA".
The development could set back Medtronic's plans, announced in December 2006, to spin off the unit into a separate, publicly...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?